‘Eclipse’ Cigarettes Higher in Carcinogens Than ‘Ultralights’

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 12
Volume 9
Issue 12

WASHINGTON-Several health groups have demanded that R.J. Reynolds Co. withdraw its new Eclipse cigarette from test marketing after an analysis showed that the cigarette exposes smokers to greater amounts of carcinogens than two currently available “ultralight” brands. The company has said that Eclipse contains fewer carcinogens than other cigarettes and may reduce the risk of smoking-related cancers.

WASHINGTON—Several health groups have demanded that R.J. Reynolds Co. withdraw its new Eclipse cigarette from test marketing after an analysis showed that the cigarette exposes smokers to greater amounts of carcinogens than two currently available “ultralight” brands. The company has said that Eclipse contains fewer carcinogens than other cigarettes and may reduce the risk of smoking-related cancers.

The study was commissioned by the Massachusetts Department of Public Health and released at a press conference held in conjunction with the American Cancer Society (ACS), American Heart Association (AHA), and Campaign for Tobacco-Free Kids. “RJR’s health claims on the Eclipse cigarette are ludicrous,” said John R. Kelly, PhD, chairman of the board of the ACS.

According to the Campaign for Tobacco-Free Kids, cardiovascular disease (43%) and cancer (36%) account for 79% of the more than 400,000 smoking-related deaths that occur in the United States each year. “Obviously, judging by the study, smoking an Eclipse cigarette is not ‘the next best thing to quitting,’ as RJR has promoted, but is one of the best ways to wind up dead from heart disease and stroke,” said M. Cass Wheeler, chief executive officer of the AHA.

The analysis, carried out by LabStat International, Inc., of Kitchener, Ontario, compared the chemicals in the smoke of Eclipse with those of Now and Carlton. Eclipse produced the same amount or more of the strong carcinogens found in the tobacco smoke of the other two brands. These chemicals included nitrosamines, acetaldehyde, acrolein, and benzo(a)-pyrene. Moreover, Eclipse smoke contained more carbon monoxide than Now and Carlton.

“In light of our research, R.J. Reynolds’ claim that Eclipse has 80% less carcinogens in the smoke than the typical ultralight appears to be false and misleading,” said Greg Connolly, director of the Massachusetts Health Department’s Tobacco Control Program. “Further, the use of R.J. Reynolds’ data to make health claims about reduced risk of cancer also appears to be false and misleading.”

Eclipse uses a charcoal heat source containing a small amount of tobacco at its tip, which burns. The heat from the burning tip passes through a length of tobacco, which doesn’t burn, and glycerin, which vaporizes. The result is smoke and flavor reaching the smoker. Reynolds says Eclipse burns only about 3% of the tobacco in a traditional cigarette.

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content